G. Lopaschuk
Surgery · 2000–2021
A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Surgery — 34 citations into it
Whom G. Lopaschuk trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts G. Lopaschuk overall
Papers from G. Lopaschuk's perspective
Ordered by how strongly the researchers G. Lopaschuk trusts endorse each paper. Same corpus, a different order for every researcher.
- A novel mouse model of lipotoxic cardiomyopathy. (Journal of Clinical Investigation)
- Cardiac remodeling in obesity. (Physiological Reviews)
- Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. (The Lancet)
- Myocardial fatty acid metabolism in health and disease. (Physiological Reviews)
- Trends in prevalence and outcome of heart failure with preserved ejection fraction. (New England Journal of Medicine)
- Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance (Proceedings of the National Academy of Sciences of the United States of America)
- Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes (Diabetes, obesity and metabolism)
- Outcome of heart failure with preserved ejection fraction in a population-based study. (New England Journal of Medicine)
- Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association (Circulation)
- Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. (European Heart Journal)
Their papers
- A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. (2007) — 1,563 citations
- Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. (2008) — 1,957 citations
- The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. (2002) — 1,002 citations
- Myocardial fatty acid metabolism in health and disease. (2010) — 2,101 citations
- Cardiac Energy Metabolism in Heart Failure (2021) — 1,028 citations
- Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors (2020) — 728 citations
- Lancet Seminar: Cardiovascular Remodelling in Coronary Artery Disease and Heart Failure (2014) — 664 citations
- Myocardial substrate metabolism in the normal and failing heart. (2005) — 2,054 citations
- The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. (2000) — 858 citations